Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
doi: 10.1037/h0055542 12 ZhangZHZuoQHWuXR
Fernando Gallardo has received fees as presenter, consultant, and support for attendance of course and congresses and/or investigation projects in the following companies: Janssen, Abbvie, UCB, Amgen, Bristol, Lilly, Novartis, Almirall, Leo Pharma
An "Impact x Nightline" episode now streaming on Hulu examines the ever-growing popularity of weight loss drugs and their effect on user's mental health and personal relationships
Retatrutide's Phase 2a in MASH/MASLD (Sanyal et al., Nat Med 2024) reported approximately 86% relative reduction in liver fat content at 12 mg/week the strongest hepatic-fat data among the incretin class
Open 7 (2), e2354734
US$ 26.26
US$ 25.59
US$ 25.44
US$ 23.73
US$ 22.24
US$ 22.75
US$ 26.53
US$ 26.14
US$ 21.07
US$ 29.62
US$ 24.84
